Apollo Medical Holdings, Inc., a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company serves the patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organizations; and non-insured patients in California. Apollo Medical Holdings, Inc. was founded in 1994 and is headquartered in Alhambra, California.
Industry, Sector and Symbol
Industry Management consulting services
Sub-IndustryN/A
SectorMedical
Phone626-282-0288
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$519.91 million
Profitability
Miscellaneous
Employees475
Next Earnings Date11/13/2019 (Estimated)
OptionableNot Optionable
Apollo Medical (NASDAQ:AMEH) Frequently Asked Questions
What is Apollo Medical's stock symbol?
Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."
How were Apollo Medical's earnings last quarter?
Apollo Medical Holdings Inc (NASDAQ:AMEH) announced its quarterly earnings data on Friday, August, 9th. The company reported $0.09 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.05 by $0.04. The business earned $130.05 million during the quarter. Apollo Medical had a net margin of 1.94% and a return on equity of 5.28%. View Apollo Medical's Earnings History.
When is Apollo Medical's next earnings date?
Has Apollo Medical been receiving favorable news coverage?
News headlines about AMEH stock have been trending very negative this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Apollo Medical earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Apollo Medical.
Are investors shorting Apollo Medical?
Apollo Medical saw a increase in short interest in the month of September. As of September 30th, there was short interest totalling 1,680,000 shares, an increase of 87.4% from the August 30th total of 896,600 shares. Based on an average trading volume of 216,100 shares, the days-to-cover ratio is presently 7.8 days. Currently, 16.0% of the shares of the company are sold short. View Apollo Medical's Current Options Chain.
Who are some of Apollo Medical's key competitors?
Some companies that are related to Apollo Medical include ICF International (ICFI), Huron Consulting Group (HURN), NIC (EGOV), RMR Group (RMR), Navigant Consulting (NCI), Gopher Protocol (GOPH), The Hackett Group (HCKT), Blackrock Capital Investment (BKCC), Avalon Globocare (AVCO), Information Services Group (III), ATIF (ATIF), China Internet Nationwide Fncl Srvcs (CIFS), Wilhelmina International (WHLM), Lightbridge (LTBR) and Pharma Bio Serv (PBSV).
What other stocks do shareholders of Apollo Medical own?
Who are Apollo Medical's key executives?
Apollo Medical's management team includes the folowing people:
- Dr. Kenneth T. Sim M.D., Exec. Chairman
- Dr. Thomas S. Lam, CEO & Director (Age 70)
- Mr. Eric Chin, Chief Financial Officer
- Mr. Hing Ang, Chief Operating Officer
- Dr. Albert Young M.D., Co-Chief Medical Officer
Who are Apollo Medical's major shareholders?
Apollo Medical's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Manchester Financial Inc. (0.18%). Company insiders that own Apollo Medical stock include Adrian Vazquez, Albert Waichow Young, Eric Chin, John Chiang, Kenneth T Sim, Mark Fawcett, Michael F Eng, Thomas S Lam and Warren Hosseinion. View Institutional Ownership Trends for Apollo Medical.
Which institutional investors are selling Apollo Medical stock?
AMEH stock was sold by a variety of institutional investors in the last quarter, including Manchester Financial Inc.. Company insiders that have sold Apollo Medical company stock in the last year include Adrian Vazquez and Warren Hosseinion. View Insider Buying and Selling for Apollo Medical.
How do I buy shares of Apollo Medical?
Shares of AMEH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Apollo Medical's stock price today?
One share of AMEH stock can currently be purchased for approximately $15.37.
How big of a company is Apollo Medical?
Apollo Medical has a market capitalization of $551.78 million and generates $519.91 million in revenue each year. The company earns $10.84 million in net income (profit) each year or $0.29 on an earnings per share basis. Apollo Medical employs 475 workers across the globe.View Additional Information About Apollo Medical.
What is Apollo Medical's official website?
How can I contact Apollo Medical?
Apollo Medical's mailing address is 1668 S. Garfield Avenue 2nd Floor, Alhambra CA, 91801. The company can be reached via phone at 626-282-0288 or via email at [email protected]
MarketBeat Community Rating for Apollo Medical (NASDAQ AMEH)
MarketBeat's community ratings are surveys of what our community members think about Apollo Medical and other stocks. Vote "Outperform" if you believe AMEH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMEH will underperform the S&P 500 over the long term. You may vote once every thirty days.
